Major Autohemotherapy
After an intravenous line is placed, blood from the individual is mixed with ozone and reinfused into the patient. MAH has successfully treated patients with coronary artery disease, cerebrovascular disease, gangrene, macular degeneration, chronic fatigue states, acute and chronic infections, and autoimmune disorders; it can also be beneficial for cancer patients before, during, and after conventional treatment.
$150 each Non-members: $225
Package of 5 treatments: $675
Package of 5 treatments for $1015


